ABILIFY costs a pharmacy a median of $18.67 per unit. Its generic equivalent costs $0.1252, which makes the brand 149.1 times the price of the same molecule. That is what the pharmacy pays to acquire it. It is not your price: a dispensing fee and margin sit between this number and your receipt.
Retail comparison starts to lose to formulary tier and assistance programmes. The acquisition cost tells you what is being negotiated over, not what you will pay.
Acquisition cost percentile, 3,439 priced products
This sits in the middle of the corpus, the range where where-you-fill-it genuinely changes the total.
Acquisition cost per unit, CMS's own correspondence
$18.67 against $0.1252. The generic bar is drawn to scale, which is why it is barely visible at 149.1x. CMS publishes this correspondence per product, so it is a comparison of the same thing rather than a match on names.
Between the cheapest tenth of listings and the dearest tenth, ABILIFY varies by 1.4 times. That is a tight band. Pharmacies are buying it at close to the same price, so a difference in what you are charged is a difference in fees and margin rather than in the drug.
Mental Health Medication Assistance (Multiple Programs). [object Object] Estimated saving: Generic antidepressants cost $4-15/month; brand-name PAPs save $500-2,000+/month.
Every figure here is CMS NADAC, the federal survey of what retail pharmacies pay to acquire a drug. It is public-domain federal data and it is the cleanest available floor. It excludes your dispensing fee, your pharmacy's margin, your insurance design and any discount-card pricing, all of which sit between this number and what you hand over. Nothing here is medical advice.
Source: CMS NADAC (National Average Drug Acquisition Cost), Centers for Medicare & Medicaid Services, dataset generated 2026-07-22. See how ABILIFY compares across 385 brand and generic pairs, or look up another drug in our price tools.